![Laura Aguilar](https://www.abta.org/wp-content/uploads/2024/02/laura-aguilar-2024-march-square-300x300.png)
American Brain Tumor Association Announces New Board of Directors Officers and Members
Meet the ABTA’s newest Board Members, Laura Aguilar, MD, PhD, and Charles (Chad) Schafer, JD.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Meet the ABTA’s newest Board Members, Laura Aguilar, MD, PhD, and Charles (Chad) Schafer, JD.
Read our top takeaways from the Society for Neuro-Oncology (SNO) Annual Meeting, the world’s largest gathering of neuro-oncology experts.
Discover how a brain tumor diagnosis led Bri to live a more fulfilling life and how she’s helping others do the same.
A new year brings new opportunities to make a difference in the brain tumor community and empower yourself!
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.
For National Family Caregivers Month, Robin Ferrill shares tips from her experience embracing the role after her husband’s GBM diagnosis in 2022.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways:
Always free for patients & caregivers
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631